Literature DB >> 23579480

Surface analysis of PEGylated nano-shields on nanoparticles installed by hydrophobic anchors.

M F Ebbesen1, B Whitehead, B Ballarin-Gonzalez, P Kingshott, K A Howard.   

Abstract

PURPOSE: This work describes a method for functionalisation of nanoparticle surfaces with hydrophilic "nano-shields" and the application of advanced surface characterisation to determine PEG amount and accumulation at the outmost 10 nm surface that is the predominant factor in determining protein and cellular interactions.
METHODS: Poly(lactic-co-glycolic acid) (PLGA) nanoparticles were prepared with a hydrophilic PEGylated "nano-shield" inserted at different levels by hydrophobic anchoring using either a phospholipid-PEG conjugate or the copolymer PLGA-block-PEG by an emulsification/diffusion method. Surface and bulk analysis was performed including X-ray photoelectron spectroscopy (XPS), nuclear magnetic resonance spectroscopy (NMR) and zeta potential. Cellular uptake was investigated in RAW 264.7 macrophages by flow cytometry.
RESULTS: Sub-micron nanoparticles were formed and the combination of (NMR) and XPS revealed increasing PEG levels at the particle surface at higher PLGA-b-PEG copolymer levels. Reduced cellular interaction with RAW 264.7 cells was demonstrated that correlated with greater surface presentation of PEG.
CONCLUSION: This work demonstrates a versatile procedure for decorating nanoparticle surfaces with hydrophilic "nano-shields". XPS in combination with NMR enabled precise determination of PEG at the outmost surface to predict and optimize the biological performance of nanoparticle-based drug delivery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579480     DOI: 10.1007/s11095-013-1018-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands.

Authors:  Stefan Fischer; Christina Foerg; Sabine Ellenberger; Hans P Merkle; Bruno Gander
Journal:  J Control Release       Date:  2005-12-27       Impact factor: 9.776

Review 2.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

3.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.

Authors:  H Murakami; M Kobayashi; H Takeuchi; Y Kawashima
Journal:  Int J Pharm       Date:  1999-10-05       Impact factor: 5.875

4.  A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery.

Authors:  Yutao Liu; Kai Li; Bin Liu; Si-Shen Feng
Journal:  Biomaterials       Date:  2010-09-22       Impact factor: 12.479

5.  Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.

Authors:  M Kappy; T Stuart; A Perelman; R Clemons
Journal:  J Clin Endocrinol Metab       Date:  1989-11       Impact factor: 5.958

Review 6.  Micellar nanocarriers: pharmaceutical perspectives.

Authors:  V P Torchilin
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.200

7.  PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution.

Authors:  Farnaz Esmaeili; Mohammad Hossein Ghahremani; Behnaz Esmaeili; Mohammad Reza Khoshayand; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Int J Pharm       Date:  2007-08-06       Impact factor: 5.875

8.  Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery.

Authors:  Sae-Byeok Shin; Hea-Young Cho; Dae-Duk Kim; Han-Gon Choi; Yong-Bok Lee
Journal:  Eur J Pharm Biopharm       Date:  2009-08-22       Impact factor: 5.571

9.  Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex).

Authors:  K J Walker; A O Turkes; A Turkes; R Zwink; C Beacock; A C Buck; W B Peeling; K Griffiths
Journal:  J Endocrinol       Date:  1984-11       Impact factor: 4.286

10.  Pegylated phospholipids-based self-assembly with water-soluble drugs.

Authors:  Yiguang Wang; Ruiqi Wang; Xiaoyan Lu; Wanliang Lu; Chunling Zhang; Wei Liang
Journal:  Pharm Res       Date:  2009-12-22       Impact factor: 4.200

View more
  1 in total

1.  Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells.

Authors:  Morten F Ebbesen; Morten Tj Olesen; Mikkel C Gjelstrup; Malgorzata M Pakula; Esben Ku Larsen; Irene M Hansen; Pernille L Hansen; Jan Mollenhauer; Birgitte M Malle; Kenneth A Howard
Journal:  Pharm Res       Date:  2014-11-01       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.